Biocon Limited (BOM:532523)
India
· Delayed Price · Currency is INR 352.10
+0.50 (0.14%)
At close: Jun 23, 2025
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
9.35M INR
Profits / Employee
621.08K INR
Market Cap
472.92B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 347,362 |
| HDFC Bank | 214,521 |
| Tata Consultancy Services | 607,979 |
| Bharti Airtel | 28,673 |
| ICICI Bank | 187,765 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Life Insurance Corporation of India | 98,661 |
Biocon News
- 12 days ago - Biocon shares in focus as company reportedly plans to launch QIP to raise up to Rs 4,500 crore - Business Upturn
- 19 days ago - Biocon launches BioWISE program to empower women in STEM across Karnataka - Business Upturn
- 25 days ago - Top stocks to watch today, June 3: HCLTech, Mphasis, Britannia Industries, Torrent Power, Biocon and more - Business Upturn
- 25 days ago - Stocks to watch on June 3: Biocon, PTC India Financial, HCL Tech, Yes Bank, Maruti, Reliance Infra, Aptus Value, Zinka Logistics, Adani Group in focus - Business Upturn
- 26 days ago - Biocon receives CDSCO approval for its Liraglutide drug in India - Business Upturn
- 4 weeks ago - ‘Metro Mentor’ moment: Kiran Mazumdar-Shaw ditches car, hops on Bengaluru Metro with Exxon Mobil’s ‘Iron Lady’; calls ride ‘quick way to avoid traffic’ - The Times of India
- 4 weeks ago - Biocon Biologics receives UK MHRA approval for YESINTEK, Biosimilar Ustekinumab - Business Upturn
- 5 weeks ago - Biocon subsidiary and Yoshindo expand access to Ustekinumab Biosimilar in Japan - Business Upturn